---
created: 2025-04-13
updated: 2025-04-13T10:52
id: :2X@q:R3l
specialty: endo
specialty_id: 76
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - "source/ak-step1-v11:": 
  - theme/b&b::08-endocrinology::05-other::02-parathyroid-glands
  - "source/ak-step1-v11:": 
  - theme/firstaid::11-musculoskeletal-skin-connective-tissue::04-pharm::07-denosumab
  - "source/ak-step1-v11:": 
  - theme/nbme::21
  - "source/ak-step1-v11:": 
  - theme/ome::14-endocrine::04-parathyroid::01-healthy-parathyroid
  - "source/ak-step1-v11:": 
  - source/ome-banner::clinical::07-endocrinology
  - "source/ak-step1-v11:": 
  - theme/physeo::03-physiology::06-endocrinology::04-calcium-homeostasis
  - "source/ak-step1-v11:": 
  - theme/sketchypharm::05-gi-&-endocrine::03-thyroid,-parathyroid-&-adrenal::02-bisphosphonates,-raloxifene,-denosumab,-calcitonin
  - "source/ak-step1-v11:": 
  - theme/uworld::100-999::600-699::639
  - source/ak-step1-v11::^other::^highyield::1-highyield
  - source/ak-step1-v11::^systems::endocrine::pharmacology"
type: flashcard
---

# Question
Chronic exposure of PTH stimulates osteoblasts to express **RANKL**, which binds to **RANK** on osteoclast surfaces to increase activity

---

# Answer
RANKL = receptor activator of nuclear factor kappaB ligand  Also stimulates proliferation and differentiation of osteoclast precursors